$1.15
+0.01(1.33%)
Mkt Cap $879M
$1.10
$1.58
52-Week Range
At a Glance
AI-generatedRevenue breakdown: Service (65.9%), Product (15.4%), Transfer Of Intellectual Property And Other (14.8%).
8-K
OPKO Health, Inc. appointed Subbarao V. Uppaluri, Ph.D. as a new director effective March 18, 2026, to serve until the 2026 Annual Meeting of Stockholders, filling the vacancy from the passing of Dr. Richard Krasno. Dr. Uppaluri, determined independent, is expected to join the Compensation Committee and will receive standard non-employee director compensation.$879M
Market Cap
$609M
Revenue
-$226M
Net Income
Employees2,997
Fundamentals
How The Business Makes Money
Revenue by Segment
Service65.9%($4.1B)
Product15.4%($959M)
Transfer Of Intellectual Property And Other14.8%($922M)
Rayaldee3.2%($196M)
Royalty0.6%($36M)
Germany Price Approval By Local Sick Fund Association0.1%($7M)
First Marketing Approval Of Rayaldee In Europe0%($3M)
Revenue by Geography
US72.4%($1.6B)
IE11%($241M)
CL9%($196M)
ES3.4%($75M)
MX3.2%($70M)
IL0.6%($12M)
Other Countries0.4%($10M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000944809
ISINUS68375N1037
CUSIP68375N103
Phone305 575 4100
Address4400 Biscayne Boulevard, Miami, FL, 33137, US
SEC EDGAR